Stockreport

Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial [Yahoo! Fi...

Cartesian Therapeutics, Inc.  (RNAC) 
PDF gravis demonstrating an MG-ADL improvement of =3 points at Month 4 relative to placebo Deepening responses observed over time in Phase 2b trial, with Descartes-08-trea [Read more]